/

BreezeBio

Developing nanoparticle-based delivery platforms for genetic medicines.

BiotechnologyPharmaceuticals

breezebio.com ↗

Company facts

Founded: 2016
Employees: 63
Headquarters: United States
Type: Private
Funding: Series B · $60M · 2026